Diagnosis and pathogenesis of CNS lupus (Q31166031)

29 June 2017

1 reference

title

Diagnosis and pathogenesis of CNS lupus (English)

1 reference

29 June 2017

1 reference

13 December 2022

1 reference

13 December 2022

A. P. van Dam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1866569

13 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1866569

13 December 2022

publication date

1 January 1991

1 reference

full work available at URL

29 June 2017

http://link.springer.com/content/pdf/10.1007/BF00290244.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00290244/fulltext.html

13 December 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00290244

13 December 2022

1 reference

Rheumatology International

13 December 2022

published in

1 reference

29 June 2017

11

1 reference

29 June 2017

1

1 reference

29 June 2017

1-11

1 reference

The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies

29 June 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF00290244

Cerebral infarction associated with lupus anticoagulants--preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00290244

Cerebrovascular ischemia associated with lupus anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00290244

Ischemic stroke associated with anticardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00290244

Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00290244

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00290244

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00290244

Lupus anticoagulant, antiphospholipid antibodies and migraine

21 January 2018

1 reference

12 December 2020

Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant

1 reference

12 December 2020

Failure to detect brain reactivity of lymphocytotoxins in cerebral lupus.

1 reference

12 December 2020

Low avidity antibodies to dsDNA as a diagnostic tool

1 reference

12 December 2020

CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

1 reference

12 December 2020

Anticardiolipin antibodies in patients with systemic lupus erythematosus.

1 reference

12 December 2020

Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets

1 reference

12 December 2020

Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.

1 reference

12 December 2020

Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus

1 reference

12 December 2020

Association between Lupus Psychosis and Antiribosomal P Protein Antibodies

1 reference

12 December 2020

Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody

1 reference

12 December 2020

Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement

1 reference

12 December 2020

Systemic lupus erythematosus. A prospective analysis

1 reference

12 December 2020

Headache in patients with systemic lupus erythematosus: clinical and telethermographic findings

1 reference

12 December 2020

Migrainous phenomena in systemic lupus erythematosus

1 reference

12 December 2020

Association of IgG Anti-Brain Antibodies with Central Nervous System Dysfunction in Systemic Lupus Erythematosus

1 reference

12 December 2020

Antibodies Reactive with Neurons in SLE Patients with Neuropsychiatric Manifestations

1 reference

12 December 2020

Very late activation antigens (VLA) are human leukocyte-neuronal crossreactive cell surface antigens

1 reference

12 December 2020

Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus

1 reference

12 December 2020

Anticardiolipin antibodies in patients with rheumatic diseases

1 reference

12 December 2020

Heterogeneous neurocytotoxic antibodies in systemic lupus erythematosus

1 reference

12 December 2020

Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies

1 reference

12 December 2020

The natural history of systemic lupus erythematosus by prospective analysis

1 reference

12 December 2020

Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus

1 reference

12 December 2020

Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986

1 reference

12 December 2020

Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis

1 reference

12 December 2020

Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance

1 reference

12 December 2020

The "primary" antiphospholipid syndrome: major clinical and serological features.

1 reference

12 December 2020

High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus

1 reference

12 December 2020

The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus.

1 reference

12 December 2020

Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

1 reference

12 December 2020

Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus

1 reference

12 December 2020

Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus.

1 reference

12 December 2020

Immunological specificity and mechanism of action of IgG lupus anticoagulants

1 reference

12 December 2020

Cerebral disease in systemic lupus erythematosus

1 reference

12 December 2020

Clinical findings in patients with SLE whose sera contain antibodies to ribosomal ribonucleoprotein

1 reference

12 December 2020

High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population

1 reference

12 December 2020

Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging

1 reference

12 December 2020

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

1 reference

12 December 2020

Anorexia nervosa in a patient with systemic lupus erythematosus

1 reference

12 December 2020

Antigenic polymorphism of human very late activation protein-2 (platelet glycoprotein Ia-IIa). Platelet alloantigen Hca

1 reference

12 December 2020

Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients

1 reference

12 December 2020

The neurological manifestations of systemic lupus erythematosus

1 reference

12 December 2020

Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

Monoclonal hybridoma anti-cardiolipin antibodies from SLE mice.

1 reference

12 December 2020

Psychiatric Problems in Systemic Lupus Erythematosus

1 reference

12 December 2020

Central nervous system involvement in systemic lupus erythematosus. A study of 150 cases

1 reference

12 December 2020

An evaluation of the role of laboratory investigations in establishing a diagnosis of central nervous system lupus.

1 reference

12 December 2020

Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease

1 reference

12 December 2020

Anti-dsdna and complement profiles as prognostic guides in systemic lupus erythematosus

1 reference

12 December 2020

The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus

1 reference

12 December 2020

Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies

1 reference

12 December 2020

Antiphospholipid antibodies: more than just a disease marker?

1 reference

12 December 2020

Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant

1 reference

12 December 2020

"Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation

1 reference

12 December 2020

Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus.

1 reference

12 December 2020

Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus

1 reference

12 December 2020

Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies.

1 reference

12 December 2020

Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome

1 reference

12 December 2020

Recurrent cerebral ischemia and mitral valve vegetation in a patient with antiphospholipid antibodies

1 reference

12 December 2020

Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies

1 reference

12 December 2020

Migraine thrombocytopenia, and serotonin metabolism

1 reference

12 December 2020

Neuronal antibodies and cognitive function in systemic lupus erythematosus

1 reference

12 December 2020

The neuropsychiatric manifestations of systemic lupus erythematosus: an overview

1 reference

12 December 2020

Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study

1 reference

12 December 2020

Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test

1 reference

12 December 2020

Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus

1 reference

12 December 2020

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

12 December 2020

Central nervous system involvement in systemic lupus erythematosus. A review of clinical observations, pathophysiology, diagnosis, disease course, prognosis and therapy

1 reference

12 December 2020

Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE

1 reference

12 December 2020

Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity

1 reference

12 December 2020

The anticardiolipin syndrome

1 reference

12 December 2020

Antiphospholipid antibodies

1 reference

12 December 2020

Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies.

1 reference

12 December 2020

Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977

1 reference

12 December 2020

The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms

1 reference

12 December 2020

Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus.

1 reference

12 December 2020

Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity?

1 reference

12 December 2020

Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus

1 reference

12 December 2020

Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis

1 reference

12 December 2020

Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions.

1 reference

12 December 2020

A novel neuronal antigen identified by sera from patients with systemic lupus erythematosus

1 reference

12 December 2020

Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies

1 reference

12 December 2020

Review of septic arthritis throughout the antibiotic era

series ordinal

12

1 reference

13 December 2022

24

14

740

MC Kelly

1987

1 reference

13 December 2022

65

13

486

GRV Hughes

1986

1 reference

13 December 2022

69

17

34

C Lavalle

1990

1 reference

13 December 2022

72

15

597

PM Ford

1988

1 reference

13 December 2022

73

14

839

D Anderson

1987

1 reference

13 December 2022

76

14

723

CG Mackworth-Young

1987

1 reference

13 December 2022

Identifiers

DOI

10.1007/BF00290244

1 reference

Dimensions Publication ID

29 June 2017

0 references

1 reference